Proteomics in infectious diseases

被引:1
|
作者
Quero, Sara [1 ,2 ]
Parraga-Nino, Noerni [1 ]
Garcia-Nunez, Marian [1 ,3 ]
Sabria, Miguel [2 ,3 ,4 ]
机构
[1] Fundacio Inst Invest Germans Trias & Pujol, Unitat Malalties Infeccioses, Barcelona, Spain
[2] Univ Autonoma Barcelona, E-08193 Barcelona, Spain
[3] CIBER Enfermedades Resp, Bunyola, Illes Balears, Spain
[4] Hosp Badalona Germans Trias & Pujol, Unitat Malalties Infeccioses, Barcelona, Spain
来源
关键词
Clinical proteomics; Infectious diseases; Biomarker; ANTIBACTERIAL VACCINE DESIGN; HOST-PATHOGEN INTERACTIONS; OUTER-MEMBRANE ANTIGENS; MASS-SPECTROMETRY; QUANTITATIVE PROTEOMICS; BIOMARKER DISCOVERY; CANDIDA-ALBICANS; 2-DIMENSIONAL ELECTROPHORESIS; STAPHYLOCOCCUS-AUREUS; IDENTIFICATION;
D O I
10.1016/j.eimc.2014.07.015
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Infectious diseases have a high incidence in the population, causing a major impact on global health. In vitro culture of microorganisms is the first technique applied for infection diagnosis which is laborious and time consuming. In recent decades, efforts have been focused on the applicability of "Omics" sciences, highlighting the progress provided by proteomic techniques in the field of infectious diseases. This review describes the management, processing and analysis of biological samples for proteomic research. (C) 2014 Elsevier Espana, S.L.U. and Sociedad Espargola de Enfermedades Infecciosas y Microbiologia Clinica. All rights reserved.
引用
收藏
页码:253 / 260
页数:8
相关论文
共 50 条
  • [1] Proteomics in infectious diseases
    不详
    [J]. JOURNAL OF PROTEOMICS, 2018, 180 : III - IV
  • [2] A Perspective on Proteomics of Infectious Diseases
    Venkatesh, Apoorva
    Gil, Concha
    Fuentes, Manuel
    LaBaer, Joshua
    Srivastava, Sanjeeva
    [J]. PROTEOMICS CLINICAL APPLICATIONS, 2018, 12 (04)
  • [3] The contribution of proteomics to the study of infectious diseases
    Castagnino, Juan Miguel
    [J]. ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2009, 43 (01): : 1 - 2
  • [4] Genomics and proteomics for infectious diseases Introduction
    Madrid-Marina, Vicente
    Lanz-Mendoza, Humberto
    Henry Rodriguez, Mario
    [J]. SALUD PUBLICA DE MEXICO, 2009, 51 : S377 - S378
  • [5] Proteomics in human disease:: Cancer, heart and infectious diseases
    Jungblut, PR
    Zimny-Arndt, U
    Zeindl-Eberhart, E
    Stulik, J
    Koupilova, K
    Pleissner, KP
    Otto, A
    Müller, EC
    Sokolowska-Köhler, W
    Grabher, G
    Stöffler, G
    [J]. ELECTROPHORESIS, 1999, 20 (10) : 2100 - 2110
  • [6] Mitochondrial dysfunction in infectious diseases: Insights from genomics and proteomics analysis
    Garg, Nisha Jain
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2006, 41 : S6 - S6
  • [7] Functional genomics and proteomics for infectious diseases in the post-genomics era
    Pas, MFWT
    Claes, F
    [J]. LANCET, 2004, 363 (9418): : 1337 - 1337
  • [8] Use of genomics and proteomics to develop better diagnostic tools for use in infectious diseases
    Gismondo, MR
    De Vecchi, E
    Drago, L
    [J]. REVIEWS IN MEDICAL MICROBIOLOGY, 2004, 15 (03) : 103 - 108
  • [9] Proteomics and integrative omic approaches for understanding host-pathogen interactions and infectious diseases
    Beltran, Pierre M. Jean
    Federspiel, Joel D.
    Sheng, Xinlei
    Cristea, Ileana M.
    [J]. MOLECULAR SYSTEMS BIOLOGY, 2017, 13 (03)
  • [10] Utility of Proteomics in Emerging and Re-Emerging Infectious Diseases Caused by RNA Viruses
    Sperk, Maike
    van Domselaar, Robert
    Rodriguez, Jimmy Esneider
    Mikaeloff, Flora
    Vinhas, Beatriz Sa
    Saccon, Elisa
    Sonnerborg, Anders
    Singh, Kamal
    Gupta, Soham
    Vegvari, Akos
    Neogi, Ujjwal
    [J]. JOURNAL OF PROTEOME RESEARCH, 2020, 19 (11) : 4259 - 4274